TR200000054A2 - Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. - Google Patents
Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.Info
- Publication number
- TR200000054A2 TR200000054A2 TR2000/00054A TR200000054A TR200000054A2 TR 200000054 A2 TR200000054 A2 TR 200000054A2 TR 2000/00054 A TR2000/00054 A TR 2000/00054A TR 200000054 A TR200000054 A TR 200000054A TR 200000054 A2 TR200000054 A2 TR 200000054A2
- Authority
- TR
- Turkey
- Prior art keywords
- sustained
- release
- clarithromycin
- formulations containing
- release tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Bu bulus, sürekli salim saglayan matriks materyali olarak hidroksipropilmetilselüloz ve etkin madde oalrak klaritromisin içeren uzun etkili tabletleri kapsar. Klaritromisin, sürekli salim saglayan tabletten Mt/M =ktn ile ifade edilen bir hizla salinir. Burada n salim kinetiklerinin üssüdür ve n degeri salim mekanizmasinin tipini tayin eder. n;0.89 ile 1 arasinda oldugunda salim hizi sifir derece kinetige göre gerçeklesir ve zamandan bagimsizdir.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2000/00054A TR200000054A2 (tr) | 2000-01-05 | 2000-01-05 | Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. |
AU36329/01A AU3632901A (en) | 2000-01-05 | 2001-01-04 | Sustained release tablet formulations comprising clarithromycin |
PCT/TR2001/000002 WO2001049246A2 (en) | 2000-01-05 | 2001-01-04 | Sustained release tablet formulations comprising clarithromycin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2000/00054A TR200000054A2 (tr) | 2000-01-05 | 2000-01-05 | Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000054A2 true TR200000054A2 (tr) | 2001-08-21 |
Family
ID=21622322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00054A TR200000054A2 (tr) | 2000-01-05 | 2000-01-05 | Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3632901A (tr) |
TR (1) | TR200000054A2 (tr) |
WO (1) | WO2001049246A2 (tr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE365557T1 (de) * | 2001-08-13 | 2007-07-15 | Fond Salvatore Maugeri Clinica | Verwendung von clarithromycin zur herstellung eines medikaments für die behandlung von arthrosis deformans |
CA2405918A1 (en) * | 2001-10-01 | 2003-04-01 | Ind-Swift Limited | Controlled release macrolide pharmaceutical formulations |
EP1720524A2 (en) * | 2004-02-26 | 2006-11-15 | Ranbaxy Laboratories Limited | Extended release tablets of clarithromycin |
EP2283824B1 (en) | 2009-07-30 | 2017-04-19 | Special Products Line S.p.A. | Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0967256A (ja) * | 1995-08-31 | 1997-03-11 | Taisho Pharmaceut Co Ltd | 感冒薬 |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
-
2000
- 2000-01-05 TR TR2000/00054A patent/TR200000054A2/tr unknown
-
2001
- 2001-01-04 WO PCT/TR2001/000002 patent/WO2001049246A2/en active Application Filing
- 2001-01-04 AU AU36329/01A patent/AU3632901A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU3632901A (en) | 2001-07-16 |
WO2001049246A2 (en) | 2001-07-12 |
WO2001049246A3 (en) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20016108L (no) | Kontrollert frigivelse og smaks maskerende orale farmasöytiske sammensetninger | |
AU3454702A (en) | Pharmaceutical compositions for the oral delivery of pharmacologically active agents | |
AP1954A (en) | Controlled release compositions comprising nimesulide. | |
NO20011471L (no) | Nye orale vedvarende frigivelsesformuleringer | |
NZ507271A (en) | Fast disintegrating tablets | |
NO971206D0 (no) | Forlenget-frigjöringsformulering | |
PT1401501E (pt) | Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo | |
NO996349D0 (no) | Farmasoeytisk sammensetning som har antitumoraktivitet og/eller reduserte bivirkninger, inneholdende et antitumormiddel og et hydroksimsyrederivat | |
ATE460157T1 (de) | Pharmazeutische metformintablette mit verlängerter freisetzung | |
ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
MXPA05008153A (es) | Sistema de encapsulacion de material. | |
TR200000054A2 (tr) | Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. | |
MXPA03011317A (es) | Comprimido masticable que comprende paracetamol. | |
TR200102566T2 (tr) | Kontrollü salınan betahistin bileşimleri. | |
AR013261A1 (es) | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina | |
FI963567A (fi) | Diklofenakki-Na:a sisältävä depottabletti | |
TR200200198T2 (tr) | Düşük dozlu tabletler ve hazırlama yöntemi | |
ATE364403T1 (de) | Retardtablette hergestellt aus linearen wasserunlöslichen polysacchariden | |
ES2169980A1 (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
NO20015488L (no) | 14<beta>-H-steroler, farmasöytiske preparater som omfatter dem, og anvendelse av disse derivatene til fremstilling avmeioseregulerende medikamenter |